◀ Back to JAK3
IL3 — JAK3
Text-mined interactions from Literome
Yu et al., Oncogene 2003
:
Further biochemical analyses revealed that
IL-3 induced
Jak/Stat , Erk, and PI3 kinase pathways in SHP-2 ( -/- ) cells were impaired and reintroduction of WT SHP-2 into mutant cells partially restored IL-3 signaling
To et al., Br J Cancer 2004
(Cell Transformation, Neoplastic...) :
The
interleukin mediated
Janus kinase ( JAK ) /STAT pathway plays a crucial role in carcinogenesis
Pecaric-Petkovic et al., Blood 2009
(Hypersensitivity) :
These effects are similar to that of IL-3, but the signaling pathways engaged are distinct because IL-33 strongly activates NF-kappaB and shows a preference for p38 MAP-kinase, while
IL-3 acts through
Jak/Stat and preferentially activates ERK
Kim et al., Molecular cancer 2010
:
In addition, treatment of 32D/IL-2Rbeta cells with the compound led to a block in IL-2 dependent
activation of
JAK3/STAT5 but not
IL-3 dependent activation of JAK2/STAT5